Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC — Mesa, Arizona

Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC is a clinical research site located in Mesa, Arizona, United States 85213.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC has participated in 5 clinical trials.

Therapeutic areas: Diarrhea-predominant Irritable Bowel Syndrome, Genetic Obesity, Obesity.

Sponsors: Boston Pharmaceuticals, Rhythm Pharmaceuticals, Inc., Urovant Sciences GmbH.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC?

Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC conducted?

Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC has 5 clinical trials on record. Their work covers Diarrhea-predominant Irritable Bowel Syndrome, Genetic Obesity, Obesity.

Is Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC accredited by Crixeo Health?

Yes — Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.